TY  - GEN
AU  - Lee,Kyoo-Hyung
AU  - Lee,Je-Hwan
AU  - Lee,Jung-Hee
AU  - Kim,Dae-Young
AU  - Seol,Miee
AU  - Lee,Young-Shin
AU  - Kang,Young-Ah
AU  - Jeon,Mijin
AU  - Hwang,Hyun-Ju
AU  - Jung,Ah-Rang
AU  - Kim,Sung-Han
AU  - Yun,Sung-Cheol
AU  - Shin,Ho-Jin
TI  - Reduced-intensity conditioning therapy with busulfan, fludarabine, and antithymocyte globulin for HLA-haploidentical hematopoietic cell transplantation in acute leukemia and myelodysplastic syndrome
SN  - 1528-0020
PY  - 2011///1115
KW  - Acute Disease
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Antilymphocyte Serum
KW  - administration & dosage
KW  - Busulfan
KW  - Disease-Free Survival
KW  - Female
KW  - Graft Survival
KW  - Graft vs Host Disease
KW  - prevention & control
KW  - Granulocyte Colony-Stimulating Factor
KW  - pharmacology
KW  - HLA Antigens
KW  - analysis
KW  - Hematopoietic Stem Cell Transplantation
KW  - methods
KW  - Histocompatibility
KW  - Humans
KW  - Infections
KW  - Kaplan-Meier Estimate
KW  - Leukemia
KW  - mortality
KW  - Male
KW  - Middle Aged
KW  - Myelodysplastic Syndromes
KW  - Peripheral Blood Stem Cell Transplantation
KW  - Retrospective Studies
KW  - T-Lymphocytes
KW  - immunology
KW  - Tissue Donors
KW  - Transplantation Conditioning
KW  - Treatment Outcome
KW  - Vidarabine
KW  - Young Adult
N1  - Publication Type: Evaluation Study; Journal Article
UR  - https://doi.org/10.1182/blood-2011-02-339838
ER  -